Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in TransplantIneligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone

被引:2
|
作者
Hou, Jian [1 ]
Fu, Weijun [2 ]
Bang, Soo-Mee [3 ]
Huang, Honghui [1 ]
Kim, Kihyun [4 ]
Li, Wei [5 ]
An, Gang [6 ]
Lee, Je-Jung [7 ]
Cai, Zhen [8 ]
Jin, Jie [8 ]
Wang, Yafei [9 ]
Chim, C. S. [10 ]
Rodriguez-Otero, Paula [11 ]
Dimopoulos, Meletios A. [12 ]
Fujisaki, Tomoaki [13 ]
Lee, Jae Hoon [14 ]
Wroblewski, Susan [15 ]
Carson, Robin [15 ]
Qi, Ming [15 ]
Wang, Jianping [16 ]
Song, Yang [17 ]
Bin Jia [18 ]
Yang, Xue [18 ]
Liu, Wenyu [17 ]
Li, Yunan [19 ]
Zhang, Renyi [20 ]
Wang, Jianxiang [6 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Dept Hematol, Sch Med, Shanghai, Peoples R China
[2] Shanghai Changzheng Hosp, Shanghai, Peoples R China
[3] Seoul Natl Univ Bundang Hosp, Seoul, South Korea
[4] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[5] Jilin Univ, Dept Hematol, Ctr Oncol, Hosp 1, Changchun, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol Blood Dis Hosp, Tianjin, Peoples R China
[7] Chonnam Natl Univ, Dept Hematol Oncol, Med Sch, Jeollanamdo, South Korea
[8] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
[9] Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Dept Hematol,Key Lab Canc Prevention & Therapy, Tianjin, Peoples R China
[10] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
[11] Univ Navarra Clin, IDISNA, Navarra, Spain
[12] Natl & Kapodistrian Univ Athens, Athens, Greece
[13] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan
[14] Gachon Univ Gil Med Ctr, Incheon, South Korea
[15] Janssen Res Dev LLC, Spring House, PA USA
[16] Janssen Res Dev LLC, Raritan, NJ USA
[17] Janssen Res Dev LLC, Beijing, Peoples R China
[18] Janssen Res Dev LLC, Shanghai, Peoples R China
[19] Xian Janssen Pharmaceut Ltd, Med Affairs, Beijing, Peoples R China
[20] Xian Janssen Pharmaceut Ltd, Med Affairs, Shanghai, Peoples R China
关键词
D O I
10.1182/blood-2021-146974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1661
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
    Mateos, Maria-Victoria
    Cavo, Michele
    Blade, Joan
    Dimopoulos, Meletios A.
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Krevvata, Maria
    Wang, Jianping
    Kudva, Anupa
    Ukropec, Jon
    Wroblewski, Susan
    Kobos, Rachel
    San-Miguel, Jesus
    [J]. BLOOD, 2019, 134
  • [2] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
    Mateos, Maria-Victoria
    Dimopoulos, Meletios A.
    Cavo, Michele
    Suzuki, Kenshi
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Grosicki, Sebastian
    Crepaldi, Andre
    Liberati, Anna Marina
    Campbell, Philip
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Iida, Shinsuke
    Blade, Joan
    Ukropec, Jon
    Pei, Huiling
    Van Rampelbergh, Rian
    Kudva, Anupa
    Qi, Ming
    San-Miguel, Jesus
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : 785 - 798
  • [3] Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS
    Fu, Weijun
    Huang, Honghui
    Li, Wei
    An, Gang
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Jia, Bin
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Hou, Jian
    Wang, Jianxiang
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S125 - S125
  • [4] Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Carson, Robin
    Liu, Rui
    Zhao, Man
    Chen, Xi
    Cui, Canchan
    Hou, Jian
    Wang, Jianxiang
    [J]. ANNALS OF HEMATOLOGY, 2024,
  • [5] Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone
    Wang, Jianxiang
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, C. S.
    Rodriguez-Otero, Paula
    Liberati, Anna Marina
    Takamatsu, Hiroyuki
    Lee, Jae Hoon
    Dimopoulos, Meletios A.
    Wroblewski, Susan
    Carson, Robin
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Jia, Bin
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Hou, Jian
    [J]. BLOOD, 2021, 138
  • [6] Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Carson, Robin
    Liu, Rui
    Wang, Lingling
    Zhao, Man
    Chen, Xi
    Cui, Canchan
    Hou, Jian
    Wang, Jianxiang
    [J]. BLOOD, 2023, 142
  • [7] DARATUMUMAB PLUS BORTEZOMIB, MELPHALAN, AND PREDNISONE (D-VMP) VERSUS BORTEZOMIB, MELPHALAN, AND PREDNISONE (VMP) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS) INELIGIBLE FOR TRANSPLANT: A PHASE 3 RANDOMIZED STUDY (ALCYONE)
    Mateos, M., V
    Dimopoulos, M. A.
    Cavo, M.
    Suzuki, K.
    Jakubowiak, A.
    Knop, S.
    Doyen, C.
    Lucio, P.
    Nagy, Z.
    Kaplan, P.
    Pou
    Cook, M.
    Grosicki, S.
    Crepaldi, A.
    Liberati, A. M.
    Campbell, P.
    Shelekhova, T.
    Yoon, S. S.
    Iosava, G.
    Fujisaki, T.
    Garg, M.
    Chiu, C.
    Wang, J.
    Carson, R.
    Crist, W.
    Deraedt, W.
    Nguyen, H.
    Qi, M.
    San-Miguel, J.
    [J]. HAEMATOLOGICA, 2018, 103 : 22 - 22
  • [8] Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)
    Mateos, Maria-Victoria
    Dimopoulos, Meletios A.
    Cavo, Michele
    Suzuki, Kenshi
    Jakubowiak, Andrzej J.
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Kaplan, Polina
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Chiu, Christopher
    Wang, Jianping
    Carson, Robin
    Crist, Wendy
    Deraedt, William
    Nguyen, Marie
    Qi, Ming
    San-Miguel, Jesus F.
    [J]. BLOOD, 2017, 130
  • [9] Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Cavo, Michele
    Creixenti, Joan Blade
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Pei, Huiling
    Krevvata, Maria
    Carson, Robin
    Borgsten, Fredrik
    Dimopoulos, Meletios A.
    [J]. BLOOD, 2022, 140 : 10157 - 10159
  • [10] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    [J]. BLOOD, 2014, 124 (21)